𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Angiosarcoma of the head and neck: Review of 11 cases

✍ Scribed by William R. Panje; William J. Moran; David G. Bostwick; Victor V. Kitt


Book ID
115042466
Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
367 KB
Volume
96
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Preoperative radiotherapy and bevacizuma
✍ Bridget F. Koontz; Edward F. Miles; Mary Ann D. Rubio; John F. Madden; Samuel R. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 219 KB

## Abstract ## Background. Angiosarcoma of the face is a vascular tumor with poor local control and short median survival despite standard treatment. Bevacizumab is a humanized monoclonal antibody to vascular endothelial growth factor (VEGF), which can inhibit tumor growth. It is synergistic with